Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose SKA cytokines versus DMARDs for maintenance of low disease activity in rheumatoid arthritis
2011-003016-23Phase 4Completed
- Sponsor
- GUNA SPA
- Start
- Mar 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of interleukin-4, interleukin 10 in rheumatoid arthritis (RA), sponsored by GUNA SPA. Started Mar 2012; status: completed.
02
Drugs
interleukin-4interleukin 10
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-003016-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003016-23.